Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors

Laboratory Investigation

Volumn 79, Issue 4, 1999, Pages 407-416

  Kitange, Gaspar ^a   Shibata, Shobu ^a   Tokunaga, Yoshiharu ^a   Yagi, Nobuhiro ^a   Yasunaga, Akio ^a   Kishikawa, Masao ^b   Naito, Shinji ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; TRANSCRIPTION FACTOR; UROKINASE;

ARTICLE; BRAIN TUMOR; CANCER INVASION; CELL LINE; ENZYME ACTIVITY; GLIOMA; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

BLOOD; CULTURE MEDIA; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLIOMA; HUMANS; KINETICS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032901681     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, and McEwan RN (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245.
2. Besser D, Presta M, and Nagamine Y (1995). Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ 6:1009-1017.
3. Bhat NK, Fischinger PJ, Seth A, Watson DK, and Papas TS (1996). Pleotropic functions of ETS-1. Int J Oncol 8:841-846.
4. Busso N, Masur SK, Lazega D, Waxman S, and Ossowski L (1994). Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human endothelial cells. J Cell Biol 126:259-270.
5. Chen Z, Fisher RJ, Riggs CW, Rhim IS, and Lautenberger JA (1997). Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS 1 antisense oligonucleotides. Cancer Res 57:2013-2019.
6. Chicoine MR and Silbergeld DL (1995). Assessment of brain tumor cell motility in vivo and in vitro. J Neurosurg 82:615-622.
7. Chicoine MR, Madsen CL, and Silbergeld DL (1995). Modification of human glioma locomotion in vitro by cytokines EGF, bFGF, PDGF-bb, NGF and TNFa. Neurosurgery 36:1165-1171.
8. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolated by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
9. Crepieux P, Coll J, and Stehelin D (1994). The Ets family of proteins: Weak modulators of gene expression in quest for transcriptional partners. Crit Rev Oncog 5:615-638.
10. Del Rosso M, Anichini E, Pedersen N, Blasi F, Fibbi G, Pucci M, and Ruggiero M (1993). Urokinase-urokinase receptor interaction: Non-mitogenic signal transduction in human epithelial cells. Biochem Biophys Res Commun 190:347-352.
11. Delannoy-Courdent A, Fauquette W, Bourhis XFD, Boilly B, Vandenbunder B, and Desbiens X (1996). Expression of c-ETS-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering. Int J Dev Biol 40:1097-1108.
12. Duffy MJ (1996). Proteases as prognostic markers in cancers. Clin Cancer Res 2:613-618.
13. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Petterson RF, and Collins VP (1991). Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:22164-22172.
14. Engebraaten O, Bjerkvig R, Pedersen PH, and Laerum OD (1993). Effects of EGF, bFGF, NGF and PDGF (bb) on cell proliferation, migration and invasive capacity of human brain tumor biopsies in vitro. Int J Cancer 53:209-214.
15. Gilles F, Raes M, Stehelin D, Vandenbunder B, and Fafeur V (1996). The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in fibroblasts. Exp Cell Res 222:370-378.
16. Giovazzi R, Garofalo A, Ferri C, Lucchini V, Bone AE, Chiari S, Brown PD, Nicoletti MI, and Taraboletti G (1998). Batimastat, a synthetic inhibitor of matrix metalloproteases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts. Clin Cancer Res 4:985-992.
17. Grimaldi G, Di Fiore P, Locatelli EK, Falko Y, and Blasi F (1986). Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells. EMBO J 5:855-861.
18. Gutman A and Wasylyk B (1990). The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241-2246.
19. Hultgardh-Nilsson AB, Cercek J, Wang S, Naito S, Lovdahl C, Sharifi B, Forrester JS, and Fagin JA (1996). Regulated expression of the Ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ Res 78:589-595.
20. Iwasaka C, Tanaka K, Abe M, and Sato Y (1996). Ets-1 regulates angiogenesis by inducing the expression of uPA and MMP-1 and the migration of vascular endothelial cells. J Cell Physiol 169:522-531.
21. Jensen PJ and Rodeck U (1993). Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through TGF-alpha/EGF receptor. J Cell Physiol 155:333-339.
22. Keski-Oja J, Blasi F, Leof EB, and Moses HL (1988). Regulation of the synthesis and activity of plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-β. J Cell Biol 106:451-459.
23. Kinder DH, Berger MS, Mueller BA, and Silber JR (1993). Urokinase plasminogen activator is elevated in human astrocytic gliomas relative to the normal adjacent brain. Oncol Res 5:409-414.
24. Knox JD, Bretton L, Lynch T, Bowden TG, and Nagle RB (1998). Synthetic matrix metalloprotease inhibitor, BB-94, inhibits the invasion of neoplastic human prostate cells in a mouse model. Prostate 35:248-254.
25. Liu DF and Rabbani SA (1995). Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3. Prostate 27:269-276.
26. Lund-Johansen M, Forsberg K, Bjerkvig R, and Laerum D (1992). Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathol 84:190-197.
27. Mapstone T, McMichael M, and Goldthwait D (1991). Expression of platelet-derived growth factors, transforming growth factors, and the ros gene in a variety of primary human brain tumors. Neurosurgery 28:216-222.
28. Morks S, Laerum O, and de Ridder L (1984). Invasiveness of tumors of the central nervous system. In: Mareel M and Caiman K, editors. Invasion, experimental and clinical implications. Oxford: Medical Oxford Publications, 79-125.
29. Naito S, Shimizu S, Maeda S, Wang J, Paul R, and Fagin JA (1998). Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells. Am J Physiol 274:472-480.
30. Nakano A, Tani E, Miyazaki K, Yamamoto Y, and Furuyama J-I (1995). Matrix metalloproteases and tissue inhibitors of metalloproteases in human gliomas. J Neurosurg 83:298-307.
31. Nakayama T, Ito M, Ohtsuru A, Naito S, Nakashima M, Fagin JA, Yamashita S, and Sekine I (1996). Expression of Ets-1 proto-oncogene in human gastric carcinoma: Correlation with tumor invasion. Am J Pathol 149:1931-1939.
32. Nerlov C, Rorth P, Blasi F, and Johnsen M (1991). Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592.
33. Pedersen P-H, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR, and Laerum OD (1994). Heterogeneous response of the growth factors in (EGF, PDGF bb, TGF-α, bFGF, IL-2) on glioma spheroid growth, migration and invasion. Int J Cancer 56:255-261.
34. Rao JS, Steck PA, Mohanan S, Stetler-Stevenson WG, Liotta LA, and Sawaya R (1993). Elevated levels of Mr 92000 type IV collaganase in human brain tumors. Cancer Res 53:2208-2211.
35. Ray P, Bhatti R, Gadarowski J, Bell N, and Nasruddin S (1998). Inhibitory effect of amiloride on the urokinase plasminogen activators in prostatic cancer. Tumor Biol 19:60-64.
36. Rorth P, Nerlov C, Blasi F, and Jonhsen M (1990). Transcription factor PEA3 participate in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with EGF or phorbol-ester. Nucleic Acids Res 18:5009-5017.
37. Sawaya R, and Highsmith R (1988). Plasminogen activator activity and molecular weight patterns in human brain tumors. J Neurosurg 68:73-79.
38. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanan S, Fuller GN, McGutcheon IE, Stetler-Stevenson WG, Nicolson GL, and Rao JS (1996). Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14:35-42.
39. Stacey KJ, Fowles LF, Cotman MS, Ostrowski MC, and Hume DA (1995). Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol Cell Biol 15:3430-3441.
40. Stopell MP, Verde P, Grimaldi G, Locatelli EK, and Blasi F (1986). Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor-promoter phorbol myristate acetate. J Cell Biol 102:1235-1244.
41. Waltz DA, Natykin LR, Fujita RM, Wei Y, and Chapman HA (1997). Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between urokinase receptor and vitronectin. J Clin Invest 100: 58-67.
42. Wasylyk C and Wasylyk B (1992). Oncogenic conversion alters the transcriptional properties of ets. Cell Growth Differ 3:617-625.
43. Wasylyk C, Gutman A, Nicholson R, and Wasylyk B (1991). The C-ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 10:1127-1134.
44. Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H, Seiki M, Ishii S, and Fujinaga K (1998). The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 77:128-137.
45. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, and Chapman HA (1994). Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 266: 1926-1933.
46. Wernert N (1997). The multiple roles of tumor stroma. Int J Pathol 430:433-443.
47. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C, Dupressor T, Seitz G, Vandenbunder B, and Stehelin D (1994). Stromal expression of c-ets-1 transcription factor correlates with tumor invasion. Cancer Res 54:5683-5688.
48. Wernert N, Raes M, Lassalle P, Dehouch M, Gosselin B, Vandenbunder B, and Stehelin D (1992). C-ets-1 protooncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angio-genesis in humans. Am J Pathol 140:119-127.
49. Yamamoto M, Mohanan S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, and Rao JS (1996). Differential expression of membrane-type metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56:384-394.
50. Yamamoto M, Sawaya R, Mohanan S, Bindal AK, Brunner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL, and Rao JS (1994). Expression and localization of uPA in human astrocytomas in vivo. Cancer Res 54:3656-3661.